(Q51803923)

English

Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.

scientific article published in September 1986

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

title

Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

1 reference

Watson CB

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

Reierson N

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

Norfleet EA

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

language of work or name

English

0 references

publication date

1 September 1986

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

published in

Anesthesiology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

volume

65

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

page(s)

312-314

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

Identifiers

PubMed publication ID

3752576

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3752576

retrieved

12 April 2018

reference URL

http://europepmc.org/abstract/MED/3752576

(Q51803923)

Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)